InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Munshi Amit, Chief Executive Officer. Insider active across 4 companies, notably Arena Pharmaceuticals INC. In total, 14 reports have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €1.7m. History available since 10 August 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
5,778 shares0Common StockSEC:0001628280-26-042041:0
365,000 shares@ US$1.37100.0% of flowCommon StockSEC:0000950170-24-116780:0
Ideal exit: 18 Jul 2025 (T+270)
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-023028:0
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-011480:0
Ideal exit: 17 Jan 2025 (T+270)
117,647 shares@ US$4.2533.2% of flowClass A Ordinary SharesSEC:0001104659-23-068206:0
Ideal exit: 1 Mar 2024 (T+270)
10,500 shares@ US$98.5178.7% of flowCommon StockSEC:0001628280-22-005889:0
85,847 shares0Common StockSEC:0001628280-22-000341
85,847 shares0Common StockSEC:0001628280-22-000341:0
1,000 shares@ US$48.193.4% of flowCommon StockSEC:0001628280-21-017167
Ideal exit: 13 May 2022 (T+270)
1,000 shares@ US$48.193.4% of flowCommon StockSEC:0001628280-21-017167:0
Ideal exit: 13 May 2022 (T+270)
1,000 shares@ US$50.413.5% of flowCommon StockSEC:0001628280-21-016916
Ideal exit: 9 May 2022 (T+270)
1,000 shares@ US$50.413.5% of flowCommon StockSEC:0001628280-21-016916:0
Ideal exit: 9 May 2022 (T+270)
1,000 shares@ US$52.9153.7% of flowCommon StockSEC:0001628280-21-016504:0
Ideal exit: 7 May 2022 (T+270)
1,000 shares@ US$52.9153.7% of flowCommon StockSEC:0001628280-21-016504
Ideal exit: 7 May 2022 (T+270)
14 of 14 declarations
About Munshi Amit
Amit Munshi is the President and CEO of ARENA PHARMACEUTICALS INC. In this role, he is responsible for the strategic leadership of the company, including operations and product development. With extensive experience in the pharmaceutical sector, he guides the company towards innovation and growth. His leadership is essential for achieving the organization's objectives and strengthening its market position.
